Search research articles
Contact Us
Filters
Showing results (21-30 of 157) with videos related to
Page
of 16
Sort By:
The Lancet. HIV
|
July 5, 2020
The problem with vitamin D supplementation for tuberculosis
Anja Reuter, Jennifer Furin
The Lancet. Global Health
|
September 6, 2021
The incalculable costs of tuberculosis
Helen Cox, Jennifer Furin
The Lancet. Respiratory Medicine
|
March 28, 2016
Outbreak of multidrug-resistant tuberculosis on Daru Island
Jennifer Furin, Helen Cox
The Lancet. Infectious Diseases
|
May 5, 2022
Being heard on all-oral therapy for resistant tuberculosis
Jennifer Furin, Petros Isaakidis
Elife
|
May 3, 2017
Tuberculosis innovations mean little if they cannot save lives
Madhukar Pai, Jennifer Furin
The Lancet. Respiratory Medicine
|
November 17, 2019
Are pretomanid-containing regimens for tuberculosis a victory or a victory narrative?
Lindsay McKenna, Jennifer Furin
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases
|
November 14, 2019
Quality of drug-resistant tuberculosis care: Gaps and solutions
Zarir Udwadia, Jennifer Furin
The Lancet. Infectious Diseases
|
June 21, 2025
Unified global action needed to tackle bedaquiline-resistant tuberculosis
Anja Reuter, Jennifer Furin
American Journal of Respiratory and Critical Care Medicine
|
February 21, 2020
Clarity with INHindsight: High-Dose Isoniazid for Drug-Resistant Tuberculosis with <i>inhA</i> Mutations
Sean Wasserman, Jennifer Furin
Disaster Medicine and Public Health Preparedness
|
March 13, 2014
Tuberculosis control in acute disaster settings: case studies from the 2010 Haiti earthquake
Jennifer Furin, Trini Mathew
Page
of 16
Search research articles
Search
Showing results (21-30 of 157) with videos related to
Sort By:
Page
of 16
The Lancet. HIV
|
July 5, 2020
The problem with vitamin D supplementation for tuberculosis
Anja Reuter, Jennifer Furin
The Lancet. Global Health
|
September 6, 2021
The incalculable costs of tuberculosis
Helen Cox, Jennifer Furin
The Lancet. Respiratory Medicine
|
March 28, 2016
Outbreak of multidrug-resistant tuberculosis on Daru Island
Jennifer Furin, Helen Cox
The Lancet. Infectious Diseases
|
May 5, 2022
Being heard on all-oral therapy for resistant tuberculosis
Jennifer Furin, Petros Isaakidis
Elife
|
May 3, 2017
Tuberculosis innovations mean little if they cannot save lives
Madhukar Pai, Jennifer Furin
The Lancet. Respiratory Medicine
|
November 17, 2019
Are pretomanid-containing regimens for tuberculosis a victory or a victory narrative?
Lindsay McKenna, Jennifer Furin
Journal of Clinical Tuberculosis and Other Mycobacterial Diseases
|
November 14, 2019
Quality of drug-resistant tuberculosis care: Gaps and solutions
Zarir Udwadia, Jennifer Furin
The Lancet. Infectious Diseases
|
June 21, 2025
Unified global action needed to tackle bedaquiline-resistant tuberculosis
Anja Reuter, Jennifer Furin
American Journal of Respiratory and Critical Care Medicine
|
February 21, 2020
Clarity with INHindsight: High-Dose Isoniazid for Drug-Resistant Tuberculosis with <i>inhA</i> Mutations
Sean Wasserman, Jennifer Furin
Disaster Medicine and Public Health Preparedness
|
March 13, 2014
Tuberculosis control in acute disaster settings: case studies from the 2010 Haiti earthquake
Jennifer Furin, Trini Mathew
Page
of 16